Whalegun
Home

Mark Neumann, EVP, Chief Commercial Officer: Intra-Cellular Therapies ITCI Sell · Filed 23/02/27

Trade details

Type
Insider sale
Amount
$190,647.52
Shares · price
4,046 sh · $47.12 a share
Held after
56,440 sh
Stock
Intra-Cellular Therapies ITCI
Person
Mark NeumannEVP, Chief Commercial Officer
Trade date
23/02/24
Filed
23/02/27
Days to filing
3 days

Sold 6.7% of holdings

Share of holding sold
6.7%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/01/25~23/03/26

Mark Neumann's recent trades

  • Mark Neumann

    SellIntra-Cellular Therapies

    $1.4M

    Filed 24/08/20

  • Mark Neumann

    Sell10b5-1 planIntra-Cellular Therapies

    $573.2K

    Filed 24/03/11

  • Mark Neumann

    Sell10b5-1 planIntra-Cellular Therapies

    $301K

    Filed 24/03/11

  • Mark Neumann

    Sell10b5-1 planIntra-Cellular Therapies

    $280.2K

    Filed 24/03/11

  • Mark Neumann

    Sell10b5-1 planIntra-Cellular Therapies

    $114K

    Filed 24/03/11

Mark Neumann, Chief Officer — sold $190.6K of Intra-Cellular Therapies ITCI · 6.7% of holdings | Whalegun